Consortium of Independent Immunology Clinics (CIIC) Fall 2025 Conference
Sep 26 - Sep 28, 2025
- Title: Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study and Post-hoc Analysis on Durability of Response to a Single Dose of Oral Deucrictibant
Presenter: Joshua Jacobs, M.D.
Format: Poster Presentation
Date, time: Saturday, September 27, 8:45-9:45 a.m. ET - Title: Long-Term Safety, Efficacy and Sustained Therapeutic Exposure of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Data Snapshot Results of the CHAPTER-1 Open-Label Extension and Results of a Pharmacokinetics Study in Healthy Volunteers
Format: E-poster, digital display